Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | S3AZD8D215 |
InChI Key | MPUQHZXIXSTTDU-QXGSTGNESA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C21H25N5O4S |
Molecular Weight | 443.53 |
AlogP | 2.06 |
Hydrogen Bond Acceptor | 8.0 |
Hydrogen Bond Donor | 3.0 |
Number of Rotational Bond | 6.0 |
Polar Surface Area | 132.36 |
Molecular species | NEUTRAL |
Aromatic Rings | 3.0 |
Heavy Atoms | 31.0 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | NEDD8 activating enzyme inhibitor | PubMed |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Ligase
|
3400 | 5 | - | - | - | |
Unclassified protein
|
3400 | 180 | - | - | 91 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Leukemia, Myeloid, Acute | 3 | D015470 | ClinicalTrials |
Myelodysplastic Syndromes | 2 | D009190 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
Leukemia, Myelomonocytic, Chronic | 2 | D015477 | ClinicalTrials |
Carcinoma, Hepatocellular | 2 | D006528 | ClinicalTrials |
Cholangiocarcinoma | 2 | D018281 | ClinicalTrials |
Multiple Myeloma | 1 | D009101 | ClinicalTrials |
Mesothelioma | 1 | D008654 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | D054198 | ClinicalTrials |
Lymphoma, Large B-Cell, Diffuse | 1 | D016403 | ClinicalTrials |
Melanoma | 1 | D008545 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 905579-51-3 |
ChEBI | 145535 |
ChEMBL | CHEMBL1231160 |
DrugBank | DB11759 |
FDA SRS | S3AZD8D215 |
PDB | B39 |
PubChem | 16720766 |
SureChEMBL | SCHEMBL192875 |
ZINC | ZINC000058660702 |